CF
45
3
CMS
60
-5
O
42
-4
FDX
53
-2
ROK
51
12
EQR
60
-7
HSIC
51
-3
L
58
-6
NFLX
66
2
ALL
45
-3
ZION
52
-4
MAR
50
2
ED
40
-3
TGT
57
-4
WBA
34
-4
LLY
68
3
PM
60
10
AAP
23
-3
PBI
48
-11
SYY
50
-4
CF
45
3
CMS
60
-5
O
42
-4
FDX
53
-2
ROK
51
12
EQR
60
-7
HSIC
51
-3
L
58
-6
NFLX
66
2
ALL
45
-3
ZION
52
-4
MAR
50
2
ED
40
-3
TGT
57
-4
WBA
34
-4
LLY
68
3
PM
60
10
AAP
23
-3
PBI
48
-11
SYY
50
-4
Financhill
Back

Pacific Biosciences of California Vs. XPEL Industry Stock Comparison

Buy
54

PACB
Pacific Biosciences of California

Last Price:
1.93
Seasonality Move:
10.82%
Sell
31

XPEL
XPEL

Last Price:
34.3100
Seasonality Move:
47.92%
Buy
54
Pacific Biosciences of California (PACB) is a Buy

Is Pacific Biosciences of California a Buy, Sell or Hold?

  • The current Pacific Biosciences of California [PACB] share price is $1.92. The Score for PACB is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • PACB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
XPEL (XPEL) is a Sell

Is XPEL a Buy, Sell or Hold?

  • The current XPEL [XPEL] share price is $34.2900. The Score for XPEL is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • XPEL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PACB Stock Price Chart

What is Pacific Biosciences of California's stock price today?

  • The Pacific Biosciences of California share price today is $1.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing selling pressure, which indicates risk of future bearish movement.

XPEL Stock Price Chart

What is XPEL's stock price today?

  • The XPEL share price today is $34.2900
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XPEL is experiencing slight buying pressure.

PACB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 43.41 Sell
Chaikin Money Flow: -7971646 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.46 - 1.98) Buy
Bollinger Bands (100): (2.3 - 7.04) Sell

XPEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.12 Sell
Relative Strength Index (14 RSI): 29.87 Sell
Chaikin Money Flow: 46088 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.026 - 53.306) Sell
Bollinger Bands (100): (43.6583 - 57.8183) Sell

PACB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.99 Sell
20-day SMA: 1.78 Buy
50-day SMA: 2.67 Sell
200-day SMA: 6.85 Sell
8-day EMA: 1.99 Sell
20-day EMA: 2.01 Sell
50-day EMA: 2.81 Sell
200-day EMA: 6.13 Sell

XPEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.2 Buy
20-day SMA: 40.75 Sell
50-day SMA: 48.79 Sell
200-day SMA: 57.37 Sell
8-day EMA: 34.74 Sell
20-day EMA: 39.37 Sell
50-day EMA: 45.79 Sell
200-day EMA: 55.23 Sell

Pacific Biosciences of California Earnings Growth & PACB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.01 per share, an increase this year of $0.27 per share, and an increase next year of $0.17 per share.

XPEL Earnings Growth & XPEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and a decrease next year of $0.00 per share.

Pacific Biosciences of California Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

XPEL Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):